Danish Oil and Gas Stock News

Novo Nordisk has intensified legal and regulatory efforts to protect its GLP-1 weight loss drugs from compounded copycat versions. Hims & Hers has withdrawn its oral semaglutide product after Novo Nordisk issued legal threats and announced a patent infringement lawsuit. The FDA has publicly committed to tighter action against unapproved compounded GLP-1 medications, affecting competing offerings across the sector. For investors watching CPSE:NOVO B, this dispute is about more than...

In early February 2026, Coloplast A/S reported first-quarter 2025-2026 results showing sales of DKK 7,043 million and net income of DKK 1,397 million, alongside updated guidance for around 7% EBIT growth in constant currencies for the fiscal year. The combination of modest sales movement but higher earnings per share suggests improved profitability, which can influence how investors assess Coloplast’s operational efficiency and earnings quality. Next, we’ll examine how Coloplast’s focus on...

As European markets remain buoyant, with the STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy prevailing, investors are keenly observing potential opportunities amid recent market volatility. In this context, identifying stocks that may be undervalued relative to their intrinsic worth can be a strategic approach for those looking to capitalize on market conditions where cyclical and value-oriented segments are gaining traction.

As the pan-European STOXX Europe 600 Index reaches new highs, optimism about the eurozone economy is helping to counterbalance recent market volatility. With inflation slowing faster than forecast and key interest rates remaining steady, investors are increasingly focusing on small-cap stocks that may offer unique opportunities in this evolving landscape. Identifying promising stocks often involves looking for companies with strong fundamentals and potential growth catalysts that align well...

FLSmidth & Co. A/S ( CPH:FLS ) shareholders have had their patience rewarded with a 25% share price jump in the last...

Danske Bank A/S' ( CPH:DANSKE ) dividend will be increasing from last year's payment of the same period to DKK22.72 on...

Tryg (CPSE:TRYG) has drawn fresh attention after its Board approved a share buyback programme of up to DKK 1.0b, running until 13 May 2026, with treasury holdings now at 11,308,326 shares. See our latest analysis for Tryg. At a share price of DKK155.0, Tryg has had a softer patch recently, with a 30 day share price return of 2.64% decline and a year to date share price return of 6.12% decline, even as the 1 year total shareholder return sits at 9.82%. This suggests longer term holders have...

It's been a mediocre week for Vestas Wind Systems A/S ( CPH:VWS ) shareholders, with the stock dropping 15% to kr.165...

Ringkjøbing Landbobank (CPSE:RILBA) has given investors a lot to digest by combining its full year 2025 results, a new 40% profit distribution policy and proposed changes to its capital authorisations and share capital. See our latest analysis for Ringkjøbing Landbobank. These announcements land after a strong run in the share price, with a 30 day share price return of 9.99% and a 1 year total shareholder return of 51.35%. This suggests positive momentum has been building around Ringkjøbing...

Novo Nordisk (CPSE:NOVO B) successfully defended its intellectual property against compounded copycat versions of its Wegovy pill using semaglutide. Following legal pressure from Novo Nordisk and a stricter tone from the FDA on unauthorized compounded drugs, telehealth firm Hims & Hers withdrew its low cost semaglutide pill offering within days. At the same time, Amazon's pharmacy began offering Novo Nordisk's Wegovy pill, widening retail distribution for the FDA approved oral GLP-1...

Shareholders might have noticed that A.P. Møller - Mærsk A/S ( CPH:MAERSK B ) filed its yearly result this time last...

Pandora A/S ( CPH:PNDORA ) has announced that it will be increasing its dividend from last year's comparable payment on...

Gyldendal A/S' ( CPH:GYLD B ) investors are due to receive a payment of DKK20.00 per share on 21st of April. The...

Vestas Wind Systems (CPSE:VWS) has secured an order for the Kapuni Wind Farm in New Zealand. The project is one of New Zealand's first large-scale efforts to pair wind power with green hydrogen production. Kapuni is intended to support New Zealand's broader decarbonisation and renewable energy objectives. Kapuni adds another reference project to Vestas' core business in wind turbines and related services, while also highlighting its role in early green hydrogen projects. For you as an...

Coloplast Q1 2026 Earnings Snapshot Coloplast (CPSE:COLO B) opened its 2026 financial year with Q1 revenue of DKK 7.0b and basic EPS of DKK 6.21, alongside trailing twelve month EPS of DKK 17.70 and net income of DKK 4.0b. Over recent quarters the company has seen quarterly revenue move in a tight band between DKK 6.9b and DKK 7.0b, while quarterly EPS has ranged from DKK 3.57 to DKK 6.21 as net income shifted between DKK 805m and DKK 1.40b. This sets up this report as a check-in on how much...

The board of Novo Nordisk A/S ( CPH:NOVO B ) has announced that it will be paying its dividend of DKK7.95 on the 31st...

Last week saw the newest third-quarter earnings release from Matas A/S ( CPH:MATAS ), an important milestone in the...

Rockwool (CPSE:ROCK B) is in focus after publishing its 2025 results, issuing 2026 guidance, adjusting its dividend proposal and detailing sustainability progress. This gives investors several fresh data points to reassess the shares. See our latest analysis for Rockwool. Those 2025 results, the 2026 guidance and the adjusted dividend proposal appear to sit behind the recent moves, with a 7.10% 90 day share price return contrasting with a 15.95% decline in 1 year total shareholder return...

The ChemoMetec A/S ( CPH:CHEMM ) share price has fared very poorly over the last month, falling by a substantial 40...

It's been a good week for Danske Bank A/S ( CPH:DANSKE ) shareholders, because the company has just released its latest...

Why Jyske Bank (CPSE:JYSK) is on investors’ radar now Jyske Bank (CPSE:JYSK) has caught investor attention after a solid recent run in the share price, with returns over the past month, past 3 months and year all firmly in positive territory. See our latest analysis for Jyske Bank. The recent 1 month share price return of 11.24% and 3 month share price return of 28.69% at a DKK980.0 share price sit alongside a 1 year total shareholder return of 87.76%. This suggests momentum has been building...

There's been a notable change in appetite for GN Store Nord A/S ( CPH:GN ) shares in the week since its yearly report...

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...

Ørsted (CPSE:ORSTED) closed out FY 2025 with Q4 revenue of DKK23.1b and a basic EPS loss of DKK1.77, while trailing twelve month EPS sat at DKK1.95 on revenue of DKK73.2b. Over recent periods the company has seen quarterly revenue range from DKK12.3b to DKK23.1b and EPS swing from a profit of DKK10.57 in Q1 2025 to losses in Q3 and Q4. Investors are watching how consistently that full year profitability holds up. With trailing net income of DKK1.7b against those sizable top line figures, the...